Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 2;16(10):e70711.
doi: 10.7759/cureus.70711. eCollection 2024 Oct.

Point Shear Wave Elastography for Assessment of Liver Stiffness in Normal Individuals and in Patients With Non-alcoholic Fatty Liver Disease

Affiliations

Point Shear Wave Elastography for Assessment of Liver Stiffness in Normal Individuals and in Patients With Non-alcoholic Fatty Liver Disease

Parag V Patil et al. Cureus. .

Abstract

Background Non-alcoholic fatty liver disease (NAFLD) is an increasing health issue worldwide, driven by rising rates of diabetes, obesity, and hypertriglyceridemia. Often asymptomatic, NAFLD is diagnosed through blood tests, imaging, and sometimes liver biopsy. Some cases advance to non-alcoholic steatohepatitis (NASH), which can lead to complications like liver cirrhosis and liver failure. While liver biopsy is the standard test for diagnosis, non-invasive methods such as shear wave elastography (SWE) offer a simpler and more reproducible alternative for diagnosing NAFLD. This is crucial for early intervention and preventing the progression of liver damage. Objectives The objectives of the study were to measure and compare liver stiffness in healthy individuals and patients with NAFLD using point shear wave elastography (pSWE), as well as to correlate liver stiffness in NAFLD patients with the ultrasonographic grades of fatty liver. Materials and methods This observational study was carried out at Dr. D. Y. Patil Medical College, Hospital and Research Centre in Pune, India, from December 2022 to April 2024. The study involved 82 participants in total, with 41 patients diagnosed with NAFLD (cases) and 41 healthy individuals with a sonographically normal liver (controls). pSWE was performed on each participant to measure liver stiffness, with results expressed in kilopascals (kPa). The procedure was conducted using a Samsung HS70A ultrasound machine (Samsung Electronics Pvt. Ltd., Seoul, South Korea). Data analysis was performed using IBM SPSS Statistics for Windows, Version 26.0 (Released 2019; IBM Corp., Armonk, New York, USA). Non-parametric tests, such as the Mann-Whitney test and Kruskal-Wallis test, were used to evaluate the significance of differences. A p-value of less than 0.05 was considered statistically significant. Results The mean liver stiffness, measured in kilopascals (kPa), was higher in NAFLD patients (cases) (10±5.1 kPa) than in normal individuals (controls) (4.4±0.7 kPa). This difference was statistically significant, with a p-value of less than 0.001. A positive correlation (rho=0.848, p<0.001) was found between the ultrasonographic grade of fatty liver and liver stiffness in NAFLD patients. Conclusion Our study demonstrated that individuals with NAFLD exhibited significantly higher liver stiffness compared to healthy individuals, as measured by ultrasound SWE. These findings suggest that pSWE could serve as a valuable, non-invasive diagnostic tool for assessing liver stiffness in NAFLD patients. Additionally, pSWE holds the potential for evaluating and monitoring the progression of the disease. However, further research with larger sample sizes is necessary to determine the prognostic significance of liver stiffness in these patients.

Keywords: fatty liver; liver stiffness; non‐alcoholic fatty liver disease; point shear wave elastography; ultrasound elastography.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent was obtained or waived by all participants in this study. Institutional Ethics Sub-Committee, Dr. D. Y. Patil Medical College, Hospital and Research Centre issued approval IESC/PGS/2022/172. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Ultrasound image utilized to assess liver stiffness. The ROI is marked by a small square (yellow box), and the liver stiffness is measured within this area
ROI: region of interest; pSWE: point shear wave elastography
Figure 2
Figure 2. Box-and-whisker plot showing the comparison of liver stiffness between cases and controls
The box-and-whisker plot demonstrates that the cases (NAFLD patients) exhibited higher median liver stiffness values as well as a broader range compared to the controls (normal individuals). The blue boxes represent the IQR of liver stiffness for each group, with the dark blue lines indicating the median values. The black whiskers extend to the minimum and maximum values within 1.5 times the IQR from the first and third quartiles. The circles outside of the whiskers represent the outliers. IQR: interquartile range; NAFLD: non-alcoholic fatty liver disease
Figure 3
Figure 3. The positive statistical correlation between ultrasonographic grades of fatty liver and liver stiffness (kPa). The data points are represented by blue marks, and the red line represents the line drawn through the data points

References

    1. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO) J Hepatol. 2016;64:1388–1402. - PubMed
    1. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Watanabe S, Hashimoto E, Ikejima K, et al. J Gastroenterol. 2015;50:364–377. - PubMed
    1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Hepatology. 2016;64:73–84. - PubMed
    1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Younossi Z, Anstee QM, Marietti M, et al. Nat Rev Gastroenterol Hepatol. 2018;15:11–20. - PubMed
    1. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Hepatology. 2020;72:1605–1616. - PubMed

LinkOut - more resources